Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion

NCT05203588 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Fusion of Spine, Lumbar Region

Interventions

DRUG: Denosumab 60 mg/ml Injectable Solution [Prolia]
DRUG: calcium and vitamin D

Sponsor

Shanghai Changzheng Hospital